(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(0.36%) $81.83
(-0.81%) $2.58
(-0.10%) $2 337.30
(0.54%) $29.40
(-0.82%) $1 005.80
(-0.31%) $0.930
(-0.12%) $10.66
(-0.08%) $0.790
(0.71%) $85.60
Live Chart Being Loaded With Signals
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 39.16M |
Vidutinė apimtis | 0 |
Rinkos kapitalizacija | 0.00 |
EPS | $-8.02 ( Q2 | 2022-08-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0900 (Sector) 42.63 (Industry) 30.78 |
ATR14 | $0.109 (37.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-07-15 | Tursi James Patrick | Sell | 280 373 | 2015 Stock Incentive Plan Restricted Stock Units (RSU) |
2022-03-30 | Barry Patrick A | Sell | 42 341 | Stock Incentive Plan Performance Share Units |
2022-03-29 | Barry Patrick A | Buy | 16 957 | Ordinary Shares |
2022-03-30 | Barry Patrick A | Sell | 4 975 | Ordinary Shares |
2022-03-29 | Barry Patrick A | Sell | 4 141 | Ordinary Shares |
INSIDER POWER |
---|
-100.00 |
Last 100 transactions |
Buy: 1 677 110 | Sell: 2 033 902 |
Tūris Koreliacija
Endo International plc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Endo International plc Koreliacija - Valiuta/Žaliavos
Endo International plc Finansinės ataskaitos
Annual | 2021 |
Pajamos: | $2.99B |
Bruto pelnas: | $1.77B (59.21 %) |
EPS: | $-2.63 |
FY | 2021 |
Pajamos: | $2.99B |
Bruto pelnas: | $1.77B (59.21 %) |
EPS: | $-2.63 |
FY | 2020 |
Pajamos: | $2.90B |
Bruto pelnas: | $1.46B (50.31 %) |
EPS: | $0.800 |
FY | 2019 |
Pajamos: | $2.91B |
Bruto pelnas: | $1.35B (46.15 %) |
EPS: | $-1.870 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Endo International plc
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren\'s contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company\'s Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company\'s International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women\'s health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.